Tropical Diseases: Treatment, Prevention, and Market Opportunities

Introduction

Increased travel and environmental changes are likely to accelerate the spread of tropical infectious diseases such as malaria, dengue fever, yellow fever, and Japanese encephalitis. To stop this advance, more-effective treatments and vaccines are urgently needed. Perceiving a risk to ROI, pharma companies have often shied away from research in these areas, leaving discovery to charitable organizations. However, the expected migration of these diseases into new geographic regions, the unaddressed needs of travelers and military personnel, and the potential of emerging geographic markets have renewed pharma's interest in these diseases. The result is an expanding pipeline and the possibility of new treatments within the next ten years.

Get the Answers You Need to Shape Your Strategy

• Malaria, a signifi cant global health issue, is endemic in more than 100 countries. What are the current treatments for malaria? What are the methods used to control the spread of the disease? What vaccines are emerging for the prevention of malaria?
• Infection with dengue fever (DF) can result in symptoms that range from mild discomfort to life-threatening.
• What factors contribute to severe disease symptoms? What are the current treatments and preventives for DF? What steps are being taken to control the spread of this disease into new regions?
• Yellow fever and Japanese encephalitis (JE) are mosquito-borne viruses in the same family as DF. What treatments are available for yellow fever and JE? What are the remaining unmet needs in the treatment of these diseases? How is the JE market expected to expand over the next five years?

• Malaria: Disease defi nition and symptoms; epidemiology; diagnosis, prevention, and treatment; emerging vaccines and treatments.
• Dengue fever: Disease defi nition and symptoms; epidemiology; diagnosis and treatment; emerging vaccines and treatments.
• Other mosquito-borne diseases: Yellow fever; Japanese encephalitis.
• Commercial opportunities in tropical infectious disease: unmet needs; incentive programs; market outlook.